[Experimental arterial thrombosis. Effect of an alpha blocking agent: nicergoline].
D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D000818:Animals; D001158:Arteries; D004873:Ergolines / Q000627:therapeutic use*; D009539:Nicotinic Acids / Q000627:therapeutic use; D010973:Platelet Adhesiveness / Q000187:drug effects; D011817:Rabbits; D013927:Thrombosis / Q000517:prevention & control*
D000317:Adrenergic alpha-Antagonists; D004873:Ergolines; D009539:Nicotinic Acids
Thromboses artérielles expérimentales. Effet d'un alpha-bloquant: la nicergoline.